Cited 4 time in
Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Chan-Bum | - |
| dc.contributor.author | Bae, Sang-Cheol | - |
| dc.contributor.author | Gupta, Samar | - |
| dc.contributor.author | Rogers, Malcolm P. | - |
| dc.contributor.author | Liang, Matthew H. | - |
| dc.date.accessioned | 2021-08-02T18:30:10Z | - |
| dc.date.available | 2021-08-02T18:30:10Z | - |
| dc.date.issued | 2014-08 | - |
| dc.identifier.issn | 0889-857X | - |
| dc.identifier.issn | 1558-3163 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/25820 | - |
| dc.description.abstract | Clinical trials in many diseases are experiencing'more difficulties in achieving sufficient or timely enrollment of participants; anecdotal reports from trials of novel therapies for systemic lupus erythematosus (SLE) seem to be facing the same challenges. General factors associated with this trend include the growth of the contract research industry, increasing oversight, and high-profile accounts of scientific misconduct and fraud in research. Complicated protocols that increase participant burden, overly restrictive entry criteria, the fear of an SLE flare may also affect enrollment in SLE trials. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | W. B. Saunders Co., Ltd. | - |
| dc.title | Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.rdc.2014.05.002 | - |
| dc.identifier.scopusid | 2-s2.0-84904325193 | - |
| dc.identifier.wosid | 000339694600012 | - |
| dc.identifier.bibliographicCitation | Rheumatic Disease Clinics of North America, v.40, no.3, pp 553 - 559 | - |
| dc.citation.title | Rheumatic Disease Clinics of North America | - |
| dc.citation.volume | 40 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 553 | - |
| dc.citation.endPage | 559 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.subject.keywordPlus | RECRUITMENT | - |
| dc.subject.keywordPlus | PREVENTION | - |
| dc.subject.keywordPlus | CONSENT | - |
| dc.subject.keywordPlus | SLE | - |
| dc.subject.keywordAuthor | Systemic lupus erythematosus | - |
| dc.subject.keywordAuthor | Randomized clinical trials | - |
| dc.subject.keywordAuthor | Enrollment | - |
| dc.subject.keywordAuthor | Retention | - |
| dc.identifier.url | https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0889857X14000441?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0889857X14000441%3Fshowall%3Dtrue&referrer= | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
